3 | Treatment effect | | Continue discussion: What are we measuring when assessing "treatment effect"? Is this a histologic change? Viability of tumor cells? - Primary site
- Lymph node
Note: SSA wonders about property in this model | - Primary site
- Lymph node
Will review model. This observable pertains to the process of regression/change in the neoplasm after antineoplastic therapy. So, observable could be modeled as presence of process changes.
Still a discussion. What is being measured? (Degree of presence of tumor). Can this be reproduced...base question is tumor there or not s/p therapy...tumor gone is best...everything else is questionable for the patient |